The House of Representatives yesterday voted 230-183 to pass AHA-supported legislation (H.R. 986) that would rescind the administration’s latest guidance for states seeking a Section 1332 waiver of certain Affordable Care Act requirements. Under Section 1332 of the ACA, states can apply for a waiver of certain requirements but must demonstrate that the proposed waiver would provide access to quality health care that is at least as comprehensive and affordable as without the waiver. The Centers for Medicare & Medicaid Services and Department of the Treasury last fall issued updated guidance and four waiver concepts for states seeking Section 1332 waivers for plan year 2020 and later, which allow states to test a broader array of approaches to coverage, including promoting private plans that may offer less comprehensive coverage. The legislation also would prohibit similar guidance from being proposed in the future. The agencies this month issued a request for information seeking ideas for additional Section 1332 waiver concepts that states could consider.

Related News Articles

Headline
The government shutdown is expected to continue into next week as the Senate is expected to adjourn Oct. 23 with no plans to vote this weekend. The chamber Oct…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…
Headline
The Senate Oct. 16 failed for a 10th time to advance the continuing resolution to extend government funding and end the ongoing shutdown. The chamber adjourned…
Chairperson's File
Public
There is a saying that is very timely for our field: A smooth sea never made a skilled sailor. As we head into the final months of 2025, hospitals and health…
Headline
The federal government shutdown is expected to continue into next week as the Senate adjourned Oct. 9 after failing to pass spending legislation; senators plan…
Headline
The AHA provided a statement of record to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains.…